G1 Therapeutics Inc

NASDAQ GTHX

Data sourced from iex and EODHD
Download Data

G1 Therapeutics Inc Income Statement 2015 - 2024

This table shows the Income Statement for G1 Therapeutics Inc going from 2015 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31
Revenue
M 14 15 12 42 13 10 24 11 7 6 5 7 14 17 27 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1
Cost of Revenue
M 1 1 3 1 1 1 1 1 1 0 1 1 0 - - - - -65 23 23 18 19 16 18 17 0 0 0 0 0 0 0 0 16
Gross Profit
M 13 14 9 41 11 9 22 10 6 5 4 6 14 17 27 2 - 65 -23 -23 -18 -19 -16 -18 -17 0 0 0 0 0 0 0 0 -12
Operating Expenses
M 22 23 26 29 37 40 44 47 53 43 45 44 40 41 36 33 - 101 11 9 8 7 5 3 3 17 16 15 12 10 7 7 6 3
Selling, General, and Administrative Expenses (SG&A)
M 15 15 17 19 23 25 26 27 27 24 24 25 23 24 18 14 11 12 11 9 8 7 5 3 3 2 2 2 1 1 1 1 2 3
Research and Development (R&D) Expenses
M 7 7 9 12 15 17 20 21 26 20 21 19 17 16 18 19 20 24 23 23 18 19 16 18 17 15 14 14 11 9 6 6 4 13
Other Operating Expenses
M 0 0 0 -1 -1 -1 -1 -1 -1 -1 0 0 0 0 0 0 - 65 -23 -23 -18 -19 -16 -18 -17 0 0 0 0 0 0 0 0 -13
Costs and Expenses
M 21 21 26 28 36 39 43 46 52 43 45 43 39 - - - - 101 11 9 8 7 5 3 3 17 16 15 12 10 7 7 6 0
Operating Income
M -9 -9 -16 12 -26 -31 -22 -37 -47 -38 -41 -38 -26 -24 -10 -31 -32 -37 -34 -33 -26 -26 -21 -22 -21 -17 -16 -15 -12 -10 -7 -7 -6 -15
Interest Expense
M 2 2 2 3 3 3 3 2 2 2 1 1 1 1 1 0 - - - - - 2 0 0 2 0 0 0 0 0 0 0 0 0
Non-operating Income/Expense
M -1 -1 -1 1 -2 -2 -3 -2 -2 0 0 0 0 0 0 0 1 1 2 2 2 2 1 1 0 0 0 0 0 0 0 0 0 -5
EBT
M -10 -10 -17 10 -28 -33 -24 -39 -49 -40 -42 -39 -26 -25 -11 -31 -31 -35 -32 -31 -24 -24 -20 -21 -20 -17 -16 -15 -12 -10 -7 -7 -6 -20
Income Tax Provision
M - 1 1 1 5 0 1 2 2 0 0 0 0 0 1 0 - 0 - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Income after Tax
M - -11 -18 9 -33 -34 -25 -42 -52 -40 -42 -39 -26 -25 -12 -31 - -35 - - -24 -24 -20 -21 -20 -17 -16 -15 -12 -10 -7 -7 -6 -20
Non-Controlling Interest
M - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -8 0 0 4 4 0 0 0 1
Net Income
M - - - 9 -28 -34 -25 -39 -49 -40 -42 -39 -26 -25 -12 -31 -31 -35 -32 -31 -24 -24 -20 -21 -20 -45 -16 -15 -17 -35 0 0 0 -22
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 52,171,684.00 51,838,834.00 51,777,731.00 61,040,507.00 51,647,934.00 43,626,113.00 42,799,342.00 42,707,703.00 42,687,201.00 42,544,321.00 42,383,573.00 42,119,850.00 40,700,827.00 38,053,609.00 38,009,204.00 37,786,208.00 37,659,722.00 37,586,218.00 37,540,380.00 37,470,926.00 37,396,980.00 37,203,233.00 33,829,437.00 32,781,921.00 29,360,470.00 29,360,470.00 28,318,656.00 14,208,115.00 26,663,834.00 20,429,389.00 20,429,389.00 20,429,389.00 20,429,389.00 -
EBITDA
M -9 -9 -16 13 -25 -30 -21 -37 -47 -38 -41 -38 -25 -24 -10 -31 -32 -37 -34 -33 -26 -26 -21 -22 -21 -17 -16 -15 -12 -10 -7 -7 -6 -
Depreciation and Amortization
M 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -
EBIT
M -9 -9 -16 13 -26 -31 -22 -37 -47 -38 -41 -38 -26 -24 -10 -31 -32 -37 -34 -33 -26 -26 -21 -22 -21 -17 -16 -15 -12 -10 -7 -7 -6 -15
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 0 0 0 0
Tax Rate (Effective)
% - -9.04 -5.23 13.06 -17.89 -1.45 -5.07 -6.30 -4.90 -0.62 -0.76 -0.56 -0.52 -1.93 -8.67 -0.16 - 0.40 - - 0.27 0.25 0.00 0.00 0.00 0.00 0.00 0.00 -0.33 -0.61 0.00 0.00 -0.33 0.00
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -
Gross Profit Margin
% 92.55 91.56 74.99 96.69 88.73 90.32 95.29 90.77 90.31 93.55 87.83 87.76 98.29 100.00 100.00 100.00 - - - - - - - - - - - - - - - - - -2,338.70
Operating Income Margin
% -62.50 -60.03 -133.07 27.17 -198.87 -301.34 -91.40 -349.59 -677.79 -648.48 -846.93 -578.32 -179.60 -145.58 -36.64 -1,440.28 - - - - - - - - - - - - - - - - - -2,954.79
Net Income Margin
% - - - 20.55 -213.15 -328.28 -107.19 -373.08 -712.72 -690.48 -874.19 -596.94 -185.98 -153.19 -43.89 -1,458.41 - - - - - - - - - - - - - - - - - -4,155.17
EBITDA Ratio
% -61.67 -59.20 -133.07 30.33 -189.29 -293.02 -89.71 -349.00 -678.24 -650.72 -845.94 -577.79 -178.90 -145.73 -37.00 -1,438.64 - - - - - - - - - - - - - - - - - -
EBIT Ratio
% -62.50 -60.03 -134.11 30.02 -198.87 -301.34 -91.40 -349.59 -677.79 -652.69 -848.35 -579.57 -179.74 -146.45 -37.54 -1,446.03 - - - - - - - - - - - - - - - - - -2,954.79
EBT Ratio
% -70.59 -67.07 -140.64 23.63 -213.15 -323.59 -102.02 -373.08 -712.72 -686.23 -867.58 -593.61 -185.00 -150.30 -40.39 -1,458.41 - - - - - - - - - - - - - - - - - -3,881.80

StockViz Staff

September 19, 2024

Any question? Send us an email